{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:15:16Z","timestamp":1794651316131,"version":"4.9.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinthera.2023.10.008","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T08:57:29Z","timestamp":1699088249000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-5118","authenticated-orcid":false,"given":"Yinuo","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronilda","family":"D'Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afroz Shareef","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Kalabic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Anschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Nudurupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kori","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujani","family":"Nannapaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Marroum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.10.008_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","article-title":"The roles of IL-17A in inflammatory immune responses and host defense against pathogens","volume":"226","author":"Iwakura","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0002","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(22)00466-4","article-title":"Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","volume":"39903","author":"Ferrante","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0003","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(22)00467-6","article-title":"Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials","volume":"399","author":"D'Haens","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0004","first-page":"1","article-title":"Efficacy, safety, patient experience, and tolerability of risankizumab administered by on-body injector for moderate to severe Crohn's disease","author":"Loftus","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinthera.2021.01.009","article-title":"Pharmacokinetic comparability of risankizumab formulations in prefilled syringe and auto-injector for subcutaneous injection","volume":"43","author":"Lon","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0006","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cpt.2831","article-title":"Population pharmacokinetic and exposure-response analyses for efficacy and safety of risankizumab in patients with active Crohn's disease","volume":"113","author":"Suleiman","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0007","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bcp.14155","article-title":"Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients","volume":"86","author":"Bruin","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0008","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5414\/CP203023","article-title":"Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates","volume":"55","author":"Jain","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2023.10.008_bib0009","unstructured":"AbbVie I. Skyrizi\u00ae (risankizumab-rzaa) [US Package Insert]. North Chicago, IL. 2023."},{"key":"10.1016\/j.clinthera.2023.10.008_bib0010","series-title":"Approval Package for: Application Number 125522Orig1s001 Repatha Injection","year":"2016"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:00:18Z","timestamp":1758963618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823004009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0149291823004009"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AbbVie Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}